Clinical Trial Update: Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Pimicotinib (ABSK021) in Tenosynovial Giant Cell Tumor, including Pigmented Villonodular Synovitis and Giant Cell Tumor of Ten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Tendon Sheath
• Pigmented Villonodular Synovitis
• Tenosynovial Giant Cell Tumor

Drugs mentioned

• Pimicotinib

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING